TY - JOUR
T1 - Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy
T2 - An advisory statement from the American Dental Association Council on Scientific Affairs
AU - Edwards, Beatrice J.
AU - Hellstein, John W.
AU - Jacobsen, Peter L.
AU - Kaltman, Steven
AU - Mariotti, Angelo
AU - Migliorati, Cesar A.
PY - 2008/12
Y1 - 2008/12
N2 - Background and Overview. In 2005, the American Dental Association (ADA) Council on Scientific Affairs convened an expert panel to develop clinical recommendations for dentists treating patients who are receiving oral bisphosphonate therapy. The Journal of the American Dental Association published the resulting report in 2006. This 2008 advisory statement is the first of projected periodic updates of the 2006 clinical recommendations. Conclusion. This 2008 advisory statement concludes, on the basis of a review of the current literature, that for patients receiving bisphosphonate therapy, the risk of developing bisphosphonate-associated osteonecrosis (BON) of the jaw apparently remains low. It also newly concludes that current screening and diagnostic tests are unreliable for predicting a patient's risk of developing the condition. This statement updates the 2006 recommendations regarding general dentistry, management of periodontal diseases, implant placement and maintenance, oral and maxillofacial surgery, endodontics, restorative dentistry and prosthodontics, and orthodontics.
AB - Background and Overview. In 2005, the American Dental Association (ADA) Council on Scientific Affairs convened an expert panel to develop clinical recommendations for dentists treating patients who are receiving oral bisphosphonate therapy. The Journal of the American Dental Association published the resulting report in 2006. This 2008 advisory statement is the first of projected periodic updates of the 2006 clinical recommendations. Conclusion. This 2008 advisory statement concludes, on the basis of a review of the current literature, that for patients receiving bisphosphonate therapy, the risk of developing bisphosphonate-associated osteonecrosis (BON) of the jaw apparently remains low. It also newly concludes that current screening and diagnostic tests are unreliable for predicting a patient's risk of developing the condition. This statement updates the 2006 recommendations regarding general dentistry, management of periodontal diseases, implant placement and maintenance, oral and maxillofacial surgery, endodontics, restorative dentistry and prosthodontics, and orthodontics.
KW - Bisphosphonate-associated osteonecrosis
KW - Osteoporosis;osteonecrosis
UR - http://www.scopus.com/inward/record.url?scp=58149231034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149231034&partnerID=8YFLogxK
U2 - 10.14219/jada.archive.2008.0110
DO - 10.14219/jada.archive.2008.0110
M3 - Article
C2 - 19047674
AN - SCOPUS:58149231034
SN - 0002-8177
VL - 139
SP - 1674
EP - 1677
JO - Journal of the American Dental Association
JF - Journal of the American Dental Association
IS - 12
ER -